Navigation Links
M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients
Date:4/9/2010

MONTREAL, QUEBEC Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center may have found a way to more accurately predict treatment outcomes in young leukemia patients using information from a common and simple complete blood count test, also known as a CBC.

The results of a retrospective study were reported at the American Society of Pediatric Hematology Oncology's (ASPHO) annual meeting today. The study illustrated that the minimal residual disease (MRD) indicator and the absolute lymphocyte count (ALC) together enable physicians to better predict which patients with acute lymphocytic leukemia (ALL) will remain disease free and who will most likely relapse.

"Our ultimate goal is to use these prognostic tools in the future to guide treatments for our patients," said Patrick Zweidler-McKay, M.D. Ph.D., assistant professor at the Children's Cancer Hospital and first author on the study. "If we know that a patient is at high-risk for relapse from the beginning, then potentially we can adjust their treatment plan to a more aggressive therapy."

For several years, MRD has been the best prognostic tool used to predict whether a patient was at high-risk for relapse. At the 2007 ASPHO annual meeting, Zweidler-McKay reported that the ALC count can also be influential in predicting prognosis of pediatric leukemia patients. In this current study, results showed that ALC is as powerful as MRD, if not more, in independently predicting prognosis for children with ALL. By using ALC as a prognostic tool along with MRD, researchers were able to define a subgroup of patients who are more prone to relapse but were originally overlooked based on using MRD alone to predict prognosis.

The study was based on 171 pediatric ALL patients and showed that after a month of treatment, patients who were MRD positive with a low ALC had an event-free survival rate of 33 percent and an overall 5-year survival outcome of 41 percent. However, those who were MRD positive but with a high ALC had an event-free survival rate of 69 percent and overall 5-year survival of 92 percent. The most positive outcomes come from patients who are MRD negative and have high ALC. These patients have a 99 percent overall 5-year survival.

"MRD is an important tool for predicting prognosis," said Zweidler-McKay, "but it misses a subgroup of patients who, despite have low MRD, still are at high risk of relapse. Using the ALC information, we can define which patients fall into this category. Down the line, we hope this information will allow us to alter treatment to help prevent these patients from relapsing."


'/>"/>

Contact: Sara Farris
sfarris@mdanderson.org
713-792-9133
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Related medicine news :

1. M. D. Anderson study questions true favorability of rare breast cancer type
2. David Anderson to discuss what model organisms can teach us about emotion
3. LodgeNet Healthcare Deploys Custom Education Solution for M. D. Anderson Cancer Center
4. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
5. Costly tests may not help detect bladder cancer recurrence, M. D. Anderson study finds
6. Ultrasound measurement of fetal adrenal gland a better predictor of preterm birth
7. A better sign of blood vessel narrowing and early coronary artery disease
8. Sleep and Do Better
9. Genital Herpes Reactivation Better Understood
10. Couples who say we do better at resolving conflicts
11. Computers do better than humans at measuring some radiology images
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: